178 related articles for article (PubMed ID: 33521161)
1. A Systematic Literature Review and Indirect Treatment Comparison of Efficacy of Repository Corticotropin Injection versus Synthetic Adrenocorticotropic Hormone for Infantile Spasms.
Duchowny MS; Chopra I; Niewoehner J; Wan GJ; Devine B
J Health Econ Outcomes Res; 2021 Jan; 8(1):1-9. PubMed ID: 33521161
[No Abstract] [Full Text] [Related]
2. Acthar® Gel (repository corticotropin injection) dose-response relationships in an animal model of epileptic spasms.
Le JT; Frost JD; Swann JW
Epilepsy Behav; 2021 Mar; 116():107786. PubMed ID: 33548914
[TBL] [Abstract][Full Text] [Related]
3. Treatment modalities for infantile spasms: current considerations and evolving strategies in clinical practice.
Hollenshead PP; Jackson CN; Cross JV; Witten TE; Anwar AI; Ahmadzadeh S; Shekoohi S; Kaye AD
Neurol Sci; 2024 Feb; 45(2):507-514. PubMed ID: 37736852
[TBL] [Abstract][Full Text] [Related]
4. Clinical and Economic Evaluation of Repository Corticotropin Injection: A Narrative Literature Review of Treatment Efficacy and Healthcare Resource Utilization for Seven Key Indications.
Philbin M; Niewoehner J; Wan GJ
Adv Ther; 2017 Aug; 34(8):1775-1790. PubMed ID: 28660550
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics and Pharmacodynamics of Repository Corticotropin Injection Compared With Synthetic ACTH
Poola N; Due B; Wright D; Brooks LR; Zaman F
Clin Pharmacol Drug Dev; 2022 Apr; 11(4):502-515. PubMed ID: 34528408
[TBL] [Abstract][Full Text] [Related]
6. Characterization of the Clinical Evidence Supporting Repository Corticotropin Injection for FDA-Approved Indications: A Scoping Review.
Tran KA; Harrod C; Bourdette DN; Cohen DM; Deodhar AA; Hartung DM
JAMA Intern Med; 2022 Feb; 182(2):206-217. PubMed ID: 34902005
[TBL] [Abstract][Full Text] [Related]
7. Prednisolone/prednisone as adrenocorticotropic hormone alternative for infantile spasms: a meta-analysis of randomized controlled trials.
Li S; Zhong X; Hong S; Li T; Jiang L
Dev Med Child Neurol; 2020 May; 62(5):575-580. PubMed ID: 31903560
[TBL] [Abstract][Full Text] [Related]
8. Adrenocorticotropic hormone for the treatment of West Syndrome in children.
Shumiloff NA; Lam WM; Manasco KB
Ann Pharmacother; 2013 May; 47(5):744-54. PubMed ID: 23606552
[TBL] [Abstract][Full Text] [Related]
9. ACTH Treatment of Infantile Spasms: Low-Moderate- Versus High-Dose, Natural Versus Synthetic ACTH-A Retrospective Cohort Study.
Riikonen R; Lähdetie J; Kokki H
Pediatr Neurol; 2020 Oct; 111():46-50. PubMed ID: 32951660
[TBL] [Abstract][Full Text] [Related]
10. ACTON PROLONGATUM® suppresses spasms head to head with Acthar® Gel in the model of infantile spasms.
Chern CR; Chern CJ; Velíšková J; Velíšek L
Epilepsy Behav; 2020 Apr; 105():106950. PubMed ID: 32092460
[TBL] [Abstract][Full Text] [Related]
11. Neuroinflammation in Children With Infantile Spasms: A Prospective Study Before and After Treatment With Acthar Gel (Repository Corticotropin Injection).
Chugani HT; Kumar A
J Child Neurol; 2020 Oct; 35(12):808-812. PubMed ID: 32576069
[TBL] [Abstract][Full Text] [Related]
12. Acthar Gel (RCI): A Narrative Literature Review of Clinical and Economic Evidence.
Wan GJ; Niewoehner J; Hayes K
Clinicoecon Outcomes Res; 2023; 15():499-512. PubMed ID: 37397803
[TBL] [Abstract][Full Text] [Related]
13. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
14. Repository corticotropin injection versus corticosteroids for protection against renal damage in a focal segmental glomerulosclerosis rodent model.
Hayes K; Warner E; Bollinger C; Wright D; Fitch RM
BMC Nephrol; 2020 Jun; 21(1):226. PubMed ID: 32539845
[TBL] [Abstract][Full Text] [Related]
15. Pain and Fatigue Improvements in Patients Treated with Repository Corticotropin Injection Across Five Indications: A Narrative Review.
Girman C; Panaccio MP; Hayes K; Niewoehner J; Wan GJ
Adv Ther; 2022 Jul; 39(7):3072-3087. PubMed ID: 35635646
[TBL] [Abstract][Full Text] [Related]
16. Medication Utilization Patterns 90 Days Before Initiation of Treatment with Repository Corticotropin Injection in Patients with Infantile Spasms.
Gold LS; Nazareth TA; Yu TC; Fry KR; Mahler NH; Rava A; Waltrip Ii RW; Hansen RN
Pediatric Health Med Ther; 2019; 10():195-207. PubMed ID: 32099512
[TBL] [Abstract][Full Text] [Related]
17. Real-World Treatment Patterns and Outcomes from an Electronic Medical Records Database for Patients with Rheumatoid Arthritis Treated with Repository Corticotropin Injection.
Hayes K; Panaccio MP; Houston P; Niewoehner J; Fahim M; Wan GJ; Dhillon B
Open Access Rheumatol; 2021; 13():315-323. PubMed ID: 34703332
[TBL] [Abstract][Full Text] [Related]
18. Treatment of children with infantile spasms: A network meta-analysis.
Jain P; Sahu JK; Horn PS; Chau V; Go C; Mahood Q; Arya R
Dev Med Child Neurol; 2022 Nov; 64(11):1330-1343. PubMed ID: 35765990
[TBL] [Abstract][Full Text] [Related]
19. Randomized, Single-Blind, Parallel Clinical Trial on Efficacy of Oral Prednisolone Versus Intramuscular Corticotropin on Immediate and Continued Spasm Control in West Syndrome.
Wanigasinghe J; Arambepola C; Sri Ranganathan S; Sumanasena S; Attanapola G
Pediatr Neurol; 2015 Sep; 53(3):193-9. PubMed ID: 26216500
[TBL] [Abstract][Full Text] [Related]
20. A Narrative Review of Repository Corticotropin Injection for the Treatment of Systemic Lupus Erythematosus.
Askanase AD; Furie RA
Adv Ther; 2022 Jul; 39(7):3088-3103. PubMed ID: 35641860
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
